Pfizer and Bayer in deal for pipeline diabetes, obesity treatments
Pfizer and Bayer have entered an agreement granting Pfizer worldwide rights to Bayer’s pipeline DGAT-1 inhibitor treatments for obesity and ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.